Helen Of Troy
- Market cap
- 595.11M
- P/E (TTM)i
- -1.43
- P/Bi
- 0.71
- EPSi
- -39.08
- Div yieldi
- 0.00%
- 52W posi
- 70%
Anonymous reader poll. Unscientific, not investment advice.
Valuation each multiple against its own 5-year range
Vs. peers Household & Personal Products
| Company | Market cap | P/E (TTM)i | P/Bi | Div yieldi |
|---|---|---|---|---|
| Helen Of Troy (HELE) | 595.11M | -1.43 | 0.71 | 0.00% |
| Procter & Gamble (PG) | 343.34B | 22.33 | 6.44 | 2.88% |
| Unilever (UL) | 131.32B | 12.85 | 7.24 | 3.65% |
| Colgate-Palmolive (CL) | 69.52B | 34.33 | 294.63 | 2.40% |
| Estee Lauder (EL) | 34.22B | 188.90 | 8.99 | 1.48% |
| Kenvue (KVUE) | 33.67B | 20.62 | 3.19 | 4.73% |
Other StockVane-tracked companies in the same industry.
Morningstar
Trading 55.8% below Morningstar's fair value estimate.
Fair value
Helen Of Troy Ltd earns a 5-star quantitative star rating, indicating our belief that this share class offers a compelling opportunity for investors. The stock currently trades at a 36% discount to our quantitative fair value estimate of $39.82 per share; however, caution is warranted due to this estimate's high uncertainty rating.
The company's valuation metrics bolster our fair value estimate. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. Reflecting the firm's valuation is its book value yield of 135.5%, which falls in the top 20% compared with global peers. The market price is low relative to the book (accounting) value of the company's equity, which contributes to our view that shares are undervalued.
The company's profitability is an additional encouraging factor. Highly profitable companies are often more resilient in recessions and are likely to generate stronger future cash flows for shareholders. The firm's sales yield of 292.8%, a core component of profitability, lies in the top 20% globally. This company has a robust ability to generate sales without much capital investment, freeing up more capital to be returned to shareholders in the long run. This characteristic further promotes our favorable price/fair value ratio.
Economic moat
With its quantitative economic moat rating of none, this business is unlikely to consistently outearn its cost of capital without structural protection from competition. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.
By Quantitative Equity Report
Quote time 2026-10-08 09:20:34 · For reference only, not investment advice and not tailored to your situation.